Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
FHTX · against 1,336 other Healthcare companies
Ranked #857 of 1,337 · scores higher than 33% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 30–39, including FHTX · Click a bar to see the companies
Mainly because of its free cash flow yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | FHTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -46.0% | 1.5% | 6% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 19624.4% | 4.2% | 100% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -66.6% | -1.0% | 3% | 20% | |
| Book yieldHigher is better · 1,306 reported | -64.8% | 37.9% | 1% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 857 | 213M USD | 33 | ||
| 857 | 109M USD | 33 | 47 | |
| 857 | 216M USD | 33 | 44 | |
| 857 | 34M USD | 33 | 19 | |
| 857 | 126M USD | 33 | 32 | |
| 857 | 285M USD | 33 | 38 | |
| 857 | 338M USD | 33 | ||
| 857 | 24M SEK (≈$2M) | 33 | 14 | |
| 857 | 22M USD | 33 | 47 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score